コンテンツへスキップ
Merck

PHR1472

Supelco

L(+)-酒石酸

Pharmaceutical Secondary Standard; Certified Reference Material

別名:

(2R,3R)-(+)-酒石酸, L-トレアル酸

ログイン組織・契約価格を表示する


About This Item

化学式:
HO2CCH(OH)CH(OH)CO2H
CAS番号:
分子量:
150.09
Beilstein:
1725147
EC Number:
MDL番号:
UNSPSCコード:
41116107
PubChem Substance ID:
NACRES:
NA.24

グレード

certified reference material
pharmaceutical secondary standard

品質水準

認証

traceable to USP 1643340

蒸気密度

5.18 (vs air)

APIファミリー

tartaric acid

CofA

current certificate can be downloaded

自己発火温度

797 °F

包装

pkg of 1 g

テクニック

HPLC: suitable
gas chromatography (GC): suitable

mp

170-172 °C (lit.)

アプリケーション

pharmaceutical (small molecule)

フォーマット

neat

保管温度

2-30°C

SMILES記法

O[C@H]([C@@H](O)C(O)=O)C(O)=O

InChI

1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1

InChI Key

FEWJPZIEWOKRBE-JCYAYHJZSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to in-house working standards.
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to pharmacopeia primary standards
Tartaric Acid belongs to the group of carboxylic acids, and is abundantly found in grapes and wine. It is widely used in drugs, food, and beverage industry.

アプリケーション

Tartaric Acid may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using stopped-flow chemiluminescence spectrometry.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

アナリシスノート

このような2次標準は、入手可能な場合にはUSP、EP、BPの1次標準にマルチトレーサビリティを提供します。

その他情報

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

脚注

To see an example of a Certificate of Analysis for this material enter LRAC1695 in the slot below. This is an example certificate only and may not be the lot that you receive.

おすすめ製品

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

関連製品

ピクトグラム

Corrosion

シグナルワード

Danger

危険有害性情報

危険有害性の分類

Eye Dam. 1

保管分類コード

11 - Combustible Solids

WGK

WGK 1

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

PHR1472-1G-PW:
PHR1472-1G:


Choose from one of the most recent versions:

試験成績書(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Slide 1 of 9

1 of 9

Sho Isoyama et al.
Cancer science, 106(2), 171-178 (2014-12-09)
Drug resistance often critically limits the efficacy of molecular targeted drugs. Although pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) is an attractive therapeutic strategy for cancer therapy, molecular determinants for efficacy of PI3K inhibitors (PI3Kis) remain unclear. We previously identified that
Sensitive determination of periodate and tartaric acid by stopped-flow chemiluminescence spectrometry
Gaikwad A, et al.
Analyst, 119(8), 1819-1824 (1994)
Enological Chemistry, 4(8), 1819-1824 (2012)
Encyclopaedia of Occupational Health and Safety: Industries and Occupations, 4(8), 1819-1824 (1998)
Miyako Yoshida et al.
Chemical & pharmaceutical bulletin, 62(12), 1252-1258 (2014-12-03)
The objective of this study was to evaluate an improved bitterness sensor which has been developed to allow the precise and sensitive prediction of the bitterness of acidic bitter pharmaceutical active ingredients, using as examples nine non-steroidal anti-inflammatory drugs (NSAIDs).

プロトコル

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)